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The small envelope (E) protein of porcine reproductive and respiratory syndrome virus (PRRSV) is a hydrophobic 73 amino acid protein
encoded in the internal open reading frame (ORF) of the bicistronic mRNA2. As a first step towards understanding the biological role of E protein
during PRRSV replication, E gene expression was blocked in a full-length infectious clone by mutating the ATG translational initiation to GTG,
such that the full-length mutant genomic clone was unable to synthesize the E protein. DNA transfection of PRRSV-susceptible cells with the E
gene knocked-out genomic clone showed the absence of virus infectivity. P129-ΔE-transfected cells however produced virion particles in the
culture supernatant, and these particles contained viral genomic RNA, demonstrating that the E protein is essential for PRRSV infection but
dispensable for virion assembly. Electron microscopy suggests that the P129-ΔE virions assembled in the absence of E had a similar appearance to
the wild-type particles. Strand-specific RT-PCR demonstrated that the E protein-negative, non-infectious P129-ΔE virus particles were able to
enter cells but further steps of replication were interrupted. The entry of PRRSV has been suggested to be via receptor-mediated endocytosis, and
lysomotropic basic compounds and known ion-channel blocking agents both inhibited PRRSV replication effectively during the uncoating
process. The expression of E protein in Escherichia coli-mediated cell growth arrests and increased the membrane permeability. Cross-linking
experiments in cells infected with PRRSVor transfected with E gene showed that the E protein was able to form homo-oligomers. Taken together,
our data suggest that the PRRSV E protein is likely an ion-channel protein embedded in the viral envelope and facilitates uncoating of virus and
release of the genome in the cytoplasm.
© 2006 Elsevier Inc. All rights reserved.Keywords: PRRSV; Reverse genetics; Infectious clone; Small envelope protein; Uncoating; Viroporin; Oligomerization; Ion channel activityIntroduction
Porcine reproductive and respiratory syndrome virus
(PRRSV) has plagued the global swine industry leading to
significant economic losses for pig production worldwide
(Nuemann et al., 2005). PRRSV is a member of the family
Arteriviridae, which includes equine arteritis virus (EAV),
lactate dehydrogenase-elevating virus (LDV) of mice and
simian hemorrhagic fever virus (SHFV) (Meulenberg et al.,
1993; Snijder and Meulenberg, 1998). Along with the family
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doi:10.1016/j.virol.2006.07.013Nidovirales (Snijder et al., 2005). Despite the similar virion
morphology and genome organization, PRRSV is divided into
two genotypes, the European genotype (Lelystad virus; LV) and
the North American genotype, based on their antigenic and
genetic characteristics (Meng et al., 1995; Nelsen et al., 1999;
Nelson et al., 1993; Wootton et al., 2000).
PRRSV is a small, enveloped virus possessing a single-
stranded positive-sense RNA of∼15 kb in size with a 5′ cap and
a 3′ polyadenylated tail (Meulenberg et al., 1993; Sagripanti et
al., 1986; Snijder and Meulenberg, 1998; Wootton et al., 2000).
The PRRSV genome consists of the 5′ untranslated region
(UTR), nine open reading frames (ORF1a, ORF1b, ORF2a,
ORF2b and ORFs 3 through 7) and the 3′ UTR (Meulenberg et
al., 1993; Snijder and Meulenberg, 1998; Wootton et al., 2000).
Two largeORFs la and lb occupy the 5′ two-thirds of the genome
and encode 13 non-structural proteins, which are suggested to be
involved in the genome replication and transcription (Bautista et
31C. Lee, D. Yoo / Virology 355 (2006) 30–43al., 2002; van Dinten et al., 1999). The remaining ORFs, 2a
through 7 in the 3′ terminal 3 kb region, encode six membrane-
associated proteins (GP2, E, GP3, GP4, GP5 and M) present in
the envelope and nucleocapsid (N) protein (Meulenberg et al.,
1995; Wootton et al., 2000). Mature virions are spherical,
enveloped particles with a diameter of 50–65 nm and contain a
20- to 30-nm isometric core structure enclosing the genomic
RNA (Benfield et al., 1992; Dea et al., 1995).
The small envelope (E) protein is a newly identified
structural component in arteriviruses. The PRRSV E protein,
also known as 2b protein, is translated from the internal ORF
(ORF2b) starting from the +6 nucleotide position in mRNA2
(Fig. 1A). The E protein is 73 and 70 amino acids for the North
American and European type of PRRSV, respectively. The E
protein is highly hydrophobic but contains a cluster of basic
amino acids in the hydrophilic C-terminal region. The E protein
is non-glycosylated and intracellular membrane-associated
(Snijder et al., 1999; Wu et al., 2001). In PRRSV-infected
pigs, the E protein induces specific antibody (Wu et al., 2001).
Recent studies with a European PRRSV isolate showed that the
E protein is incorporated into the virions in association with
GP2–GP3–GP4 heterotrimers, suggesting a critical role for the
heteromultimeric complex in the virus entry process (Wissink et
al., 2005). Although the E protein of North American genotype
PRRSV contains two cysteine residues at positions 49 and 54, a
study has shown that E is unable to form disulfide-linked
homodimers (Lee and Yoo, 2005). In that study, cysteineFig. 1. (A) The partial genome organization of PRRSV. Genomic locations of GP2 an
the E gene-knockout full-length clone for PRRSV, P129-ΔE. Marc-145 cells were tra
incubated for 5 days. PRRSV-specific CPEs were monitored daily and photographe
fixed with cold methanol at 2 days post-transfection and incubated with the N-specifi
(green) and nsp2/3 (red) proteins for P129-WT (upper panels) or P129-ΔE (lower pan
fixed at 2 days post-transfection and co-stained with nsp2/3-specific rabbit antiserum
and nsp2/3 are co-localized.residues of the E protein were shown to be non-essential for
virus multiplication. The function and significance of E in
PRRSV replication remain to be determined.
In the present study, we investigated the role of E protein
during PRRSv replication. An infectious cDNA clone was used
to generate an E gene-knockout mutant PRRSV, and we report
here that the E protein is essential for virus infectivity but
dispensable for virus particle formation. The E protein-negative,
non-infectiousvirus particleswere able to enter cells but unable to
continue the further steps of replication. Furthermore, two ion
channel blockerswere shown togreatly affect PRRSVreplication
at early stages of infection, suggesting that ion channel activity
was essential for virus uncoating. We also found that expression
of theEprotein enhancedmembrane permeability of hygromycin
B in bacterial cells. Cross-linking studies revealed that the E
protein associated with itself into higher-order structures,
including dimers, trimers and tetramers. Our study suggests
that thePRRSVEproteinmay function as aviroporin in thevirion
envelope that facilitates uncoating of the virus in order to release
the genomic RNA into the cytoplasm for subsequent replication.
Results
Generation of E gene-knockout PRRSV
To determine the biological significance of E protein during
PRRSV infection, an E gene-knockout mutant virus wasd E genes and the E gene-knockout are illustrated. (B) Absence of infectivity of
nsfected with the full-length cDNA genomic clone of P129-WTor P129-ΔE and
d 4 days post-transfection (upper panels). For immunofluorescence, cells were
c MAb SDOW-17 (lower panels) (magnification 20×). (C) Double staining for N
els). Marc-145 cells transfected with P129-WTor P129-ΔE plasmid DNAwere
and N-specific MAb SDOW17. Yellow indicates merged images where both N
Fig. 2. trans-complementation of P129-ΔE. BHK-T7 cells were co-transfected
with P129-ΔE and pCITE-E and the culture supernatants were harvested at 48 h
post-transfection followed by inoculation to Marc-145 cells. At 24 h post-
inoculation, cells were stained with the Alexa green-labeled N-specific Mab, or
E-specific rabbit antiserum and FITC-conjugated secondary antibody. Cells
were visualized by fluorescent microscope (20×). (A) E gene (pCITE-E)
transfection; (B) P129-ΔE and pCITE-E co-transfection; (C) inoculation of
supernatant from (B) to Marc-145 cells; (D) N gene (pCITE-N) transfection; (E)
P129-ΔE and pCITE-N co-transfection; (F) inoculation of supernatant from (E)
to Marc-145 cells.
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ORF2b (E gene) was modified to abolish the E protein
expression. With the shuttle plasmid by site-directed mutagen-
esis, ‘ATG’ for translation initiation of ORF2b was changed to
‘GTG’ at genomic positions 12,062 to 12,064. This mutation
did not alter the amino acid sequence in ORF2a encoding GP2
protein. The A12062G modification was subsequently intro-
duced into the full-length genomic cDNA clone by subcloning
the Eco47III–BsrGI fragment obtained from the shuttle
plasmid. Transformants were screened by restriction patterns
using XmaI to determine the ligated clone, followed by
nucleotides sequencing to verify the specific modification in
the full-length genome. The resulting E gene-knockout genomic
clone was designated P129-ΔE.
Absence of infectivity for P129-ΔE
The infectivity of the E gene-knockout clone P129-ΔE was
examined by transfection of Marc-145 cells. Cells were
transfected with P129-WT or P129-ΔE, and the appearance
of CPE was monitored daily. P129-WT induced visible CPE at
3 days post-transfection and showed N-specific staining in
clusters of cells, indicating the infection and spread of virus to
neighboring cells (Fig. 1B, left panels). In contrast, transfection
of P129-ΔE did not produce any visible CPE for up to at least
7 days post-transfection, suggesting the lack of infectivity. A
few single cells exhibited N-specific fluorescence, and these
cells represent individually transfected cells with P129-ΔE
(Fig. 1B).
To rule out a possibility that an additional mutation might
have been introduced during construction of P129-ΔE, which
may have resulted in the loss of infectivity, six individual
mutant clones were independently generated. In these clones, no
mutation was identified for the ORF2 gene, and upon
transfection of cells, all six P129-ΔE mutant clones were non-
infectious (data not shown). This confirmed the conclusion that
P129-ΔE was non-viable and the absence of infectivity was due
to the lack of E protein expression, demonstrating the essential
role of E for PRRSV replication.
The transcription ability of P129-ΔE was examined by
double staining of transfected cells using the Alexa green-
labeled SDOW17 MAb specific for N and the Texas red-labeled
rabbit antiserum specific for nsp2/3 non-structural proteins (Fig.
1C). In cells transfected with P129-WT DNA, clusters of cells
were stained by both antibodies, indicating both N (green) and
nsp2/3 (red) expressions (Fig. 1C, upper panels). Merging of the
two images showed yellow regions where the two proteins co-
localized. For P129-ΔE, dual-staining of N (green) and nsp2/3
(red) was also observed but limited to transfected cells only, and
no evidence for the spread of infection was obtained (Fig. 1C,
lower panels). The dual staining demonstrated the expression of
nsp2/3 and N proteins in transfected cells, indicating the
synthesis of both non-structural and structural proteins, which
in turn suggests that the PRRSV genome replicated and mRNA
transcription occurred upon transfection of P129-ΔE DNA. The
results demonstrate that E protein expression is required for
PRRSV infectivity, but genome replication and transcriptionmay occur without E protein. It leads us to hypothesize that
either virion assembly or virus entry is interrupted in the
absence of E protein expression.
Complementation of P129-ΔE replication in cells expressing
the E protein
We next examined whether the infectivity of P129-ΔE could
be restored by provision of the E protein in trans. The E gene
was expressed in BHK-T7 cells and the expression was
confirmed by immunofluorescence staining with E-specific
antiserum (Fig. 2A). BHK-T7 cells were also suitable for
transfection of the full-length cDNA clone as N-specific
staining was detected in many cells (Figs. 2B and E). To
determine whether P129-ΔE in the E gene-transfected cells
leads to the production of infectious virus particles, BHK-T7
cells were co-transfected with P129-ΔE and E gene. The culture
supernatant was harvested at 48 h post-transfection from BHK-
T7 cells and transferred to Marc-145 cells. At 24 h post-
inoculation, Marc-145 cells were fixed, and virus infection was
examined by immunofluorescent staining with N-specific MAb.
Marc-145 cells inoculated with a culture fluid from cells co-
transfected with P129-ΔE and E gene showed bright N-specific
fluorescent signal, indicating that the P129-ΔE replication may
be rescued by trans-complementation of the E protein (Fig.
2C). In contrast, in cells inoculated with the supernatant from
co-transfection of P129-ΔE and N gene (Fig. 2F), or of P129-
ΔE and an empty plasmid (data not shown), no staining was
observed. The staining of Marc-145 cells inoculated with the
supernatant from BHK cells co-transfected with P129-ΔE and
N gene was however limited to single cells and no infectivity
was produced for up to 7 days post-inoculation (Fig. 2C),
indicating abortive infection of the P129-ΔE mutant virus in
non-complementing Marc-145 cells. Attempts to pass the
passage-1 culture supernatant to Marc-145 resulted in no
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generated by the provision of E in trans was only capable of a
single round of replication. These data demonstrated that the
inability of P129-ΔE to produce infectious virus was due to the
absence of E protein in the virions.
E protein is not required for virion assembly
Because P129-ΔE did not induce infectivity from transfec-
tion, it was of interest to examine whether PRRSV particles
were not produced in the absence of E protein. Due to a low
transfection efficiency in Marc-145 cells, BHK-21 cells were
used to achieve higher transfection efficiency. When stained
with N-specific MAb at 2 days post-transfection, numerous
cells showed N-specific fluorescence (data not shown),
indicating high levels of transfection in BHK-21 cells, which
may be sufficient for the study of particle formation. BHK-21
cells were transfected with P129-WT or P129-ΔE, and at 30 h
post-transfection, the transfected cells were radiolabeled for
1 day with [35S]methionine/cysteine. The cells were harvested
and lysed with RIPA buffer. The culture supernatants were
collected separately and centrifuged through a 20% (wt/vol)
sucrose cushion, and the resulting pellets were dissolved in
RIPA buffer. The lysates prepared from cells or supernatants
were immunoprecipitated with a mixture of individual anti-
body specific for E, N, or M and resolved by SDS–PAGE. As
shown in Fig. 3A, intracellular major viral-specific proteins
were detectable in all lysates (lower panel), confirming the
ability of P129-ΔE for transcription. Similarly, in the culture
supernatants, the three major virion proteins GP5, M and N
were clearly identified (upper panel), showing that, without EFig. 3. PRRSV particle assembly in the absence of E protein. (A) Radioimmunoprec
with P129-WTor P129-ΔE genomic clone. At 30 h post-transfection, the cells were ra
and cells were separately collected. Cell lysates were prepared and subjected to imm
from culture supernatants by ultracentrifugation, lysed in RIPA buffer and used f
antibodies, followed by SDS–15% PAGE under reducing conditions (upper pane
transfected. (B) Incorporation of genomic RNA in P129-ΔE virus particles. Culture s
nucleases in the presence (+) or absence (−) of SDS and Triton X-100, followed by pr
by electrophoresis in 1.5% agarose gel. Lane 1, molecular weight marker; lanes 2 and
5, supernatant from P129-WT-transfected cells; lanes 6 and 7, culture supernatant from
from P129-ΔE-transfected cells. Particles in the culture supernatants released from B
genomic clones were concentrated by ultracentrifugation through a 20% (wt/vol) su
visualized by electron microscopy. Scale bar, 100 nm.protein, virus particles can be produced and released. It was
not possible to detect the E protein in the cell lysates or
supernatants from P129-WT-transfected cells, and this is
probably due to the low abundance of E protein in BHK-21
cells as E is a minor protein (Wu et al., 2005). This result
suggests that the PRRSV E protein is not required for particle
formation.
Because the virus particles formed in the absence of E
protein were non-infectious, these particles were examined for
the presence of viral genome. The culture supernatants,
prepared from BHK-21 cells transfected with P129-WT or
P129-ΔE, were first incubated with both RNase A and DNase I
to remove any possible contamination of viral RNA and the
transfected DNA from cells. The digestion was carried out in the
presence or absence of detergents, followed by proteinase K
treatment to inactivate the nucleases. RNA was extracted from
samples and treated again with DNase I, and the E gene region
of PRRSV was RT-PCR-amplified and sequenced. In cell
culture media mixed with the full-length cDNA clone as a
negative control, no PCR fragment was amplified in the
presence or absence of detergents (Fig. 3B, lanes 2 and 3),
indicating the appropriateness of DNase I treatment. Although
no amplification was identified for controls (Fig. 3B, lanes 5
and 7), a 260-bp product was specifically amplified for both
samples of P129-WT and P129-ΔE treated with the nucleases
but in the absence of detergents (Fig. 3B, lanes 4 and 6).
Sequencing of the 260-bp product confirmed the stable
incorporation of the ‘A12062G’ mutation at the start codon of
the E gene in the genome from P129-ΔE particles. These
studies demonstrate that particles formed in the absence of E
protein contained the P129-ΔE genomic RNA, which in turnipitation of virus particles lacking the E protein. BHK-21 cells were transfected
diolabeled with [35S]methionine/cysteine for 24 h at 37 °C, and the supernatants
unoprecipitation with N-specific MAb (lower panel). The pellets were prepared
or immunoprecipitation with a mixture of anti-M, anti-N and anti-E-specific
l). Lane 1, mock transfected; lane 2, P129-WT transfected; lane 3, P129-ΔE
upernatants were pelleted by ultracentrifugation and the pellets were treated with
oteinase K treatment. RT-PCR was conducted for E gene amplification followed
3, culture supernatant spiked with the P129-ΔE full-length plasmid; lanes 4 and
P129-ΔE-transfected cells. (C) Electron microscopy of the culture supernatant
HK-21 cells transfected with P129-WT (upper panel) or P129-ΔE (lower panel)
crose cushion. Pellets were negatively stained by sodium phosphotungstate and
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the improper packaging of the genome.
To obtain further evidence for particle formation in the
absence of E, electron microscopy (EM) was conducted and the
microscopic appearance of P129-ΔE particles was compared to
that of P129-WT virions. At 2 days post-transfection, the
culture supernatant from BHK-21 cells was harvested and
pelleted by ultracentrifugation through a 20% (wt/vol) sucrose
cushion, followed by electron microscopy. PRRSV particles
were identified in the supernatant of cells transfected with either
P129-WT (Fig. 3C, upper panel) or P129-ΔE (Fig. 3C, lower
panel). No significant morphologic differences between P129-
WT and P129-ΔE particles were noted. Each virion for P129-
WT or P129-ΔE was a roughly spherical enveloped particle of
50–60 nm in diameter, with a densely stained core. The EM
study confirmed that PRRSV particles may be formed in the
absence of E protein and also showed that the E protein-
negative particles had similar appearance and size to wild-type
PRRSV particles.
Viral RNA detection from P129-ΔE virus
To determine if the lack of infectivity of P129-ΔE particles
was due to a low amount of virus produced from BHK-21
cells, the supernatants collected from BHK-21 cells were
blindly passaged twice in Marc-145 cells to amplify the
infectivity. Although extensive CPE was readily evident in
Marc-145 cells inoculated with either passage-1 or passage-2
of P129-WT supernatant, no CPE was detectable with passage-
1 or passage-2 of P129-ΔE supernatant, even after 5 days post-
inoculation (data not shown). To further determine infectivity
in Marc-145 cells inoculated with P129-ΔE virus, time course
immunofluorescence was carried out with the N-specific
antibody. As shown in Fig. 4A, distinct staining of N was
first observed at 12 h post-infection in Marc-145 cells
inoculated with P129-WT supernatant, and then in many
clusters of cells by 48 h post-infection, showing the spread of
infectivity to neighboring cells (upper panels). In contrast, cells
inoculated with passage-1 of P129-ΔE showed no specific
staining throughout the experiments, further indicating the lack
of infectivity (lower panels).
Because neither CPE nor N-specific staining was detectable
from serial passages of P129-ΔE virus, RT-PCR was conducted
from cells and culture supernatants inoculated with passage-1 or
passage-2 (Fig. 4B). To eliminate a possible carry-over
contamination of the transfected DNA, the RNA preparations
were treated with RNase-free DNase I prior to the E gene
amplification. A 260-bp product was amplified from both
culture media and cells that were inoculated with passage-1 or
passage-2 P129-WT virus (Fig. 4B, lanes 2, 5, 8 and 11). The
260-bp product was also obtainable from cells inoculated with
passage-1 P129-ΔE virus (Fig. 4B, lane 3), but no specific
product was amplified from the supernatant (Fig. 4B, lane 6),
nor from either supernatants or cells inoculated with passage-2
P129-ΔE virus (Fig. 4B, lanes 9 and 12). The amplified
fragment was sequenced, and the sequencing results confirmed
the ‘A12062G’ mutation at the start codon of ORF2b (data notshown). These results suggest that the E protein-negative, non-
infectious P129-ΔE virus particles entered Marc-145 cells, but
further steps beyond entry were interrupted, resulting in the
absence of infectivity.
To investigate whether the P129-ΔE virus genome under-
went replication following entry, strand-specific RT-PCR was
performed from cells inoculated with passage-1 P129-ΔE virus.
RT-PCR from P129-WT-inoculated cells yielded a specific
product of the expected size for both positive- and negative-
strand genomes and also for positive- and negative-strand
mRNA7 (Fig. 4C, lanes 3 in all panels). In contrast, only a
minimal amount was amplified for the positive-strand genome
from cells inoculated with passage-1 P129-ΔE virus (Fig. 4C,
panel i, lane 4). This product was likely derived from the
incoming genomic RNA of P129-ΔE virus. These results
indicate that P129-ΔE virus was unable to replicate, suggesting
that the lack of RNA replication of P129-ΔE virus was likely
due to an interruption during virus uncoating, a stage prior to
genome replication.
Inhibition of PRRSV replication by ion channel blockers
The E-protein-negative PRRSV particles were shown to
contain the viral genome and able to enter cells but unable to
release the viral RNA for initiation of genome replication. This
suggests that PRRS virions may contain ion channels and the E
protein may function as an ion channel protein embedded in the
viral envelope. It is postulated that PRRSV replication may be
suppressed by ion channel blocking agents if ion channel
activity is an essential requirement for PRRSV infection. This
aspect was investigated in Marc-145 cells using amantadine and
verapamil. Amantadine is known as a proton channel blocker
and verapamil is the calcium channel blocking agent. Because it
has been reported that an acidic environment is required for
PRRSV infection (Kreutz and Ackermann, 1996), basic
lysosomotropic agents including ammonium chloride and
chloroquine were also included in the study to examine their
inhibitory effects on PRRSV replication. Strand-specific RT-
PCR experiments were carried out and demonstrated that
PRRSV-infected Marc-145 cells produced reduced levels of
positive-sense genomic RNA at 2 days post-infection in the
presence of the drugs chloroquine, amantadine and verapamil
(Fig. 5A, upper panel). A relatively moderate level of suppres-
sion was observed in ammonium chloride-treated cells (lane 4).
Negative-sense genomic RNAwas not detectable in cells treated
with any of the four drugs until 2 days post-infection (middle and
lower panels, lanes 4–7), showing that the initiation of viral
RNA synthesis was inhibited by the ion channel blockers.
Furthermore, the number of PRRSV-infected cells determined
by the N protein staining was significantly reduced by individual
drugs in comparison to untreated cells (Fig. 5B, upper panels).
PRRSV-specific CPE was visible but significantly delayed by
the ion channel blockers, indicating the negative effects on virus
production (lower panels). The yields of virus production were
determined by plaque assays from the supernatants in the
presence of each drug. The virus titer in untreated cells reached
3×106 PFU/ml by 3 days post-infection (Fig. 5C). In contrast,
Fig. 4. The E protein is essential for PRRSV replication. (A) Immunofluorescence of N protein in P129-ΔE inoculated cells. The ‘passage-1’ virus was prepared as
culture supernatant harvested from BHK-21 cells transfected with P129-WT or P129-ΔE clone. Marc-145 cells were inoculated with ‘passage-1’ and fixed at the
indicated times post-inoculation, followed by staining with N-specific MAb. (B) Detection of viral RNA in culture supernatants and in Marc-145 cells inoculated with
‘passage-1’ or ‘passage-2’ virus. Total RNAwas extracted and treated with DNase I followed by RT-PCR for E gene. (C) Strand-specific detection of viral RNA in cells
by RT-PCR. Marc-145 cells were inoculated with ‘passage-1’ P129-WTor ‘passage-1’ P129-ΔE, and total cellular RNAwas extracted at 2 days post-inoculation. The
RNA was treated by DNase I and RT-PCR was conducted to amplify the region as illustrated in the figure. Numbers in parenthesis indicate the 5′ most nucleotide
position in each primer with respect to the PRRSV genome. Expected sizes of amplified products are indicated on the right of the gel.
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Fig. 5. Inhibition of PRRSV replication by ion channel blockers. (A) Strand-specific RT-PCR for N gene. The drug concentrations were used according to the
previously report (Kreutz and Ackermann, 1996). Verapamil concentration was determined by limiting dilution for cell cytotocixity in Marc-145 cells. Marc-145 cells
were treated with ammonium chloride (5 mM), chloroquine (20 μM), amantadine (1 mM) or verapamil (50 μM) for 30 min prior to PRRSV infection and the virus-
infected cells were incubated for 3 days in the presence of the drug. Total RNAwas extracted from cells at 2 days (upper and middle panels) or 3 days (lower panel)
post-infection, and strand-specific RT-PCR was conducted to detect positive-sense (upper panel) or negative-sense (middle and lower panels) genome. Lane 1,
molecular weight marker; lane 2, mock-inoculated cells; lane 3, untreated; lanes 4 to 7, treated with the indicated drug. (B) PRRSV replication in the presence of the
drug. Virus-infected, drug-treated Marc-145 cells were stained for immunofluorescence (upper panels) with N-specific MAb SDOW-17 at 2 days post-infection
(magnification 20×). PRRSV-specific CPE was monitored and photographed at 3 days post-infection (lower panels). (C) Growth kinetics of PRRSV in the presence of
drugs. Cells infected with PRRSV were incubated in the presence of the drug, and culture supernatants were harvested at the indicated times for plaque assays in
duplicate.
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in the presence of amantadine or verapamil, and the titers of virus
production in the presence of these drugs reached only to a
maximum of 5 to 8×101 PFU/ml by 3 days post-infection (Fig.
5C). These results showed that the treatment of infected cells
with ion channel blockers greatly reduced the growth rate of
PRRSV. However, when Marc-145 cells were treated with the
drugs at 30 min post-infection, no significant inhibitory effect of
virus production was observed (data not shown). Therefore, it
seems that the ion channel blockers effectively interfered with
virus uncoating, a step preceding genome replication and
consequently affected PRRSV production. It is interesting to
note that the inhibitory effect by amantadine are due to the
blocking of pores that are necessary for post-internalization
during uncoating of the virus (Wang et al., 1993).
Modification of membrane permeability by E protein and
oligomerization
Because our data suggest that ion channel activity may be
involved during uncoating and that the PRRSV E protein islikely responsible for this event, the E protein was assumed to
function as a viroporin. We examined whether the E protein
possessed general features commonly shared by other viropor-
ins (ion channel proteins). Viroporins generally contain the
properties of membrane permeability alteration and oligomer-
ization (Liao et al., 2004; Maldarelli et al., 1993; Paterson et al.,
2003; Sakaguchi et al., 1997; Torres et al., 2005), and so these
two common properties were examined for the E protein. The
effect of E expression on bacterial growth was first examined in
an inducible protein expression system. When the inner
bacterial membrane is intact, intracellular lysozymes cannot
reach the cell wall. However, permeabilized membranes allow
the lysozymes to gain access to the peptidoglycan, leading to
cell lysis. This approach has been shown to be suitable as a
permeabilization test of the inner bacterial membrane for viral
proteins (Bodelón et al., 2002; Ciccaglione et al., 1998; Liao et
al., 2004; Madan et al., 2005). The PRRSV E protein gene was
first cloned in the GST-fusion vector and expressed in Escher-
ichia coli. The growth rates of transformed cells were analyzed
spectrophotometrically. A drastic arrest of cell growth was
observed in the E gene-transformed cells upon IPTG induction,
Fig. 6. Alteration of membrane permeability by the E protein. (A) Growth kinetics of E. coli strain DH5α expressing GST, GST-N or GST-E. (B) Hygromycin B
permeability assay in bacterial cells. Cultures of the gene-transformed E. coli were induced by IPTG to express GST (lanes 1, 2), GST-N (lanes 3, 4) or GST-E (lanes 5
to 8). At 1 h post-induction, cells were incubated in the presence (+) or absence (−) of 1 mM of hygromycin B for 15 min and radiolabeled with [35S]methionine/
cysteine for 15 min. Cells were collected and lysed in sample buffer and analyzed by SDS–12% PAGE, followed by Coomassie blue staining (left panel) or
autoradiography (right panel). Lanes 1 and 2, cells expressing GST alone; lanes 3 and 4, cells expressing PRRSV N fused with GST (GST-N); lanes 5 and 6, cells
expressing PRRSV E fused with GST (GST-E); lanes 7 and 8, double amount of loading for cells expressing GST-E. Arrows indicate GST, GST-N or GST-E.
Fig. 7. PRRSV E protein oligomerization by DSP cross-linking. (A) Absence of
the disulfide-linked E protein oligomerization. HeLa cells were infected with
vTF7-3 and transfected with pCITE-E for 16 h. Cells were radiolabeled for 5 h
with [35S]methionine/cysteine, lysed with RIPA buffer and immunoprecipitated
using anti-E-specific rabbit antiserum, followed by SDS–17% PAGE under non-
reducing conditions in the absence of β-mercaptoethanol. Lane 1, N gene
(pCITE-N) transfected cells; lane 2, pCITE empty vector transfected cells; lane
3, E gene (pCITE-E) transfected cells. 2N, dimeric form of PRRSV N protein.
(B) Homo-oligomerization of the E protein by DSP cross-linking. PRRSV-
infected Marc-145 cells (lanes 1, 3), or HeLa cells expressing recombinant N
protein (lane 2) or E protein (lane 4) by vTF7-3 vaccinia virus were radiolabeled
with [35S]methionine/cysteine and cross-linked in vivo with 2 mM DSP for
30 min. Cells were lysed and immunoprecipitated with anti-E-specific rabbit
antiserum followed by SDS–17% PAGE under non-reducing conditions. The
radiographic images were obtained using a PhosphorImager. Multimeric forms
of the N or E protein are shown. Anti-N, N protein-specific MAb SDOW 17;
anti-E, E protein-specific anti-rabbit antiserum.
37C. Lee, D. Yoo / Virology 355 (2006) 30–43whereas bacteria carrying the empty plasmid or the PRRSV N
gene had no effects on their growth during the 300-min period
following induction (Fig. 6A). This finding suggests that the
expression of E affected the cell growth negatively by altering
the membrane permeability to intracellular lysozyme.
To further determine if the growth rate of cells expressing E
was the consequence of permeability modification, a hygro-
mycin B permeability assay was carried out. Hygromycin B is
normally impermeable to the membrane barrier during a short
period of time at low concentration, but it can readily penetrate
the permeabilized membrane to cause strong inhibition of
intracellular protein synthesis. The hygromycin B permeability
assay therefore is widely used to study changes of membrane
permeability as well as to identify proteins that can form pores
in lipid membranes (Aldabe et al., 1996; Arroyo et al., 1995;
Bodelón et al., 2002; Chang et al., 1999; Ciccaglione et al.,
1998; de Jong et al., 2003; Doedens and Kirkegaard, 1995; Han
and Harty, 2004; Liao et al., 2004; Madan et al., 2005). At 1 h
induction for E protein expression, hygromycin B was added to
the culture media. The cultures were further incubated for
15 min and metabolically labeled with [35S]methionine/cysteine
for 15 min, followed by SDS–PAGE of cell lysates. The
Coomassie blue staining showed that equal amounts of proteins
were loaded on the gel (Fig. 6B, left panel). Autoradiography
indicated that hygromycin B entered cells that expressed the E
protein, and protein synthesis was completely blocked in those
cells (Fig. 6B, right panel, compare lanes 5 and 6, lanes 7 and 8).
For cells expressing the GST or PRRSV N protein, hygromycin
B did not inhibit protein synthesis (compare lanes 1 and 2, lanes
3 and 4). These results indicate that the PRRSV E protein
enhanced membrane permeability in bacterial cells.
A second common property of viroporins is oligomerization.
The PRRSV E protein contains two well-conserved cysteine
residues; however, the E protein was shown not to form a
disulfide-linked homodimer (Lee and Yoo, 2005). The absence
of covalently linked homodimers of E was confirmed using the
recombinant E protein expressed in HeLa cells by vTF7-3
vaccinia virus (Fig. 7A). Although PRRSV N-N dimers of
30 kDa were readily detected in cells expressing the N protein
(lane 1), no band corresponding to the predicted dimeric form ofE was identified in non-reducing conditions (lane 3), conclud-
ing that the PRRSV E protein does not undergo cysteine-linked
homodimerization.
Because the E protein may form a non-covalent association
with itself as shown by GST-pull down assay (Lee and Yoo,
2005), the potential of E to form oligomers was further
investigated by cross-linking experiments in the presence and
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infected cells were treated with the membrane-permeable
cross-linking reagent DSP, and the cell lysates were immuno-
precipitated by N-specific MAb or E-specific antiserum
followed by SDS–PAGE under non-reducing conditions (Fig.
7B). The PRRSV N protein formed a number of higher-order
oligomers (lanes 1, 2), as reported previously (Wootton and
Yoo, 2003). When the E protein in virus-infected cells was
subjected to cross-linking, numerous multimeric forms of E
protein were identified (lane 3). The E protein multimerization
also was examined in the absence of other PRRSV proteins in
HeLa cells expressing E protein by T7 vaccinia virus, and
again higher-order multimeric forms of the E protein were
observed (lane 4), indicating that oligomerization of E is
independent of other viral proteins. Altogether, our data
indicate that the PRRSV E protein exists as non-covalently
linked oligomers in virus-infected cells and suggest that the
multimerization may be the physical basis for viroporin
formation of PRRSV E.
Discussion
The present study was conducted to investigate the role of
PRRSV E protein during virus infection. A reverse genetics
approach was used to modify the translation initiation of
ORF2b, so that the modified genome was unable to express the
E protein. Our experiments show that the absence of E protein
expression does not affect genome replication transcription but
impairs the production of infectious virus. These data indicate
that the PRRSV E protein is an essential structural component
for infectivity. The E protein however appears not to be an
essential component for particle assembly nor genomic
encapsidation. The virion particles devoid of E still contained
the viral genome and had a similar appearance to that of wild-
type virions. For infection, virus particles must proceed through
a multiple-step cycle of entry and uncoating, replication and
transcription and assembly and release. According to our
findings, the E protein does not exert an important function at
later events in the infection process such as genome replication,
particle assembly and release of virus. We have observed that
the E protein-negative, non-infectious virion particles are able
to enter cells but subsequent steps of replication are inhibited.
This suggests that the particles lacking the E protein most likely
remain in the endosome and the viral genome is not released,
which is the step between virus entry and genome replication.
The uncoating is a critical step for virus infection, during which
the lipid envelope is shed and the viral capsid is disassembled to
release the genome to initiate a replication cycle in the
cytoplasm. For viruses entering cells by receptor-mediated
endocytosis, the uncoating process occurs in the endosome
where an acidic environment triggers fusion between the viral
membrane and the endosomal membrane (reviewed by Smith
and Helenius, 2004). PRRSV enters cells through receptor-
mediated microfilament-dependent endocytosis in which a low
pH is required to trigger fusion for proper uncoating by an
unknown mechanism (Kreutz and Ackermann, 1996; Nau-
wynck et al., 1999). It is possible that an acidic pH in theendosome may lead to conformational changes of viral protein
(s) to expose hidden fusogenic domains that facilitate the fusion
between viral and endosomal membranes. However, no direct
fusion of PRRSV with the cell membrane, and no arterivirus
membrane proteins possessing the fusogenic property have
been reported. It is therefore tempting to speculate that PRRSV
may contain a viral ion channel protein to promote the
uncoating process in the endosome during the early stage of
infection. In the present study, we have shown the inhibitory
effect of ion channel blockers on PRRSV replication, indicating
that PRRSV may indeed possess virus-coded ion channels
whose activity is essential for proper uncoating for infection.
Virus-coded ion channels, or viroporins, consist of small,
highly hydrophobic proteins generally composed of 60–120
amino acids. The insertion of these proteins into membranes
creates typical hydrophilic pores or selective ion channels with
(a) hydrophobic transmembrane domain(s) facing the lipid
bilayer, leading to an alteration of membrane permeability to
ions or other small molecules (for a review, see Fischer and
Sansom, 2002; Gonzalez and Carrasco, 2003). Expression of
these membrane-active proteins may cause cellular membrane
leakiness further resulting in the development of cytopathic
changes to facilitate particle release late in infection, or may be
required to promote virus uncoating at an early stage of
infection (reviewed by Carrasco, 1995).
The PRRSV E protein structurally resembles a number of
viroporins found in other RNA viruses, in that it consists of
70–73 amino acid residues and contains central hydrophobic
sequences with a cluster of basic amino acids at the C-
terminus. The E protein localizes mainly in perinuclear
regions including the ER and the Golgi complex and
associates with intracellular membranes (Wu et al., 2001).
Interestingly, coronaviruses, another family member of the
order Nidovirales, also code for a small hydrophobic
membrane, designated E protein, which may play a crucial
role during virus morphogenesis (Fischer et al., 1998; Liu and
Inglis, 1991). In recent studies, the coronavirus E protein has
been shown to modify membrane permeability (Liao et al.,
2004; Madan et al., 2005) as well as to form cation-selective
ion channels in an artificial membrane (Wilson et al., 2004).
Our data in the current study also demonstrate the alteration
of membrane permeability by the PRRSV E protein and the
inhibition of bacterial growth by the increase of hygromycin
B penetration into bacterial cells. However, we were not able
to show similar results in mammalian cells by infection or E
gene transfection, which may be due to the different
intracellular localization of E in mammalian cells. In
PRRSV-infected cells, the E protein appears to remain in
the ER and Golgi complex, where it likely participates in
assembly of infectious progeny virus, rather than traveling to
the plasma membrane. Bacterial cells do not possess such
intracellular organelles and the expressed E protein may
accumulate at the inner bacterial membrane, leading to
membrane perturbation, and thus enhancing membrane
permeabilization. Failure to observe the direct alteration of
membrane permeability by E in mammalian cells implies that
the role of E is not linked to membrane disorganization and
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show that the E protein can form homo-oligomers, including
dimers, trimers and tetramers by non-covalent interactions.
All information obtained in the present study support the
hypothesis that the PRRSV E protein contains a potential for
a pore-forming activity and thus may function as an ion
channel for virus uncoating. The functional and structural
features of the PRRSV E protein resemble the influenza A
virus M2 protein that is best characterized as an ion-channel
protein. The M2 protein forms a homo-tetramer in the viral
membrane and functions as an ion channel. The M2 channel
allows the translocation of protons from the acidic environ-
ment of the endosome to the inner space of virions and alters
the pH in the virion. As a consequence, the M1 protein in the
virion is dissociated from the viral ribonucleoprotein complex,
which promotes the ribonucleoprotein complex traveling to
the nucleus where the influenza replication takes place (Pinto
et al., 1992; Sakaguchi et al., 1997). It is noteworthy that
PRRSV replication could be inhibited by amantadine, an
antiviral drug for influenza virus (Kreutz and Ackermann,
1996; Fig. 5). In summary, we propose a model for PRRSV
uncoating based on our findings. In this model, E proteins
form pores (ion channels) in the viral envelope. Upon
internalization by receptor-mediated endocytosis through
small clathrin-like coated vesicles, the virion particles are
transported to the endosome. There, the E-protein ion
channels in the viral membrane undergo conformational
changes upon exposure to low pH in the endosome, and
allow ions to enter the virion, which triggers the disassembly
of inner capsid and the release of viral genome in the
cytoplasm, such that further steps of genome replication and
infection cycle can proceed.
Materials and methods
Cells, viruses, antibodies and plasmids
Marc-145 (Kim et al., 1993), HeLa and BHK-21 cells
were grown in Dulbecco's modified Eagle medium (DMEM)
supplemented with 8% fetal bovine serum (FBS; Invitrogen),
penicillin (100 U/ml) and streptomycin (50 μg/ml). BHK-T7
cells stably expressing the bacteriophage T7 RNA polymerase
(generously provided by C.Y. Kang, University of Western
Ontario, London, Ontario, Canada) were grown in DMEM
supplemented with 5% FBS, 100 U/ml of penicillin, 50 μg/ml
of streptomycin and 500 μg/ml of G418 (Geneticin;
Invitrogen). The cells were maintained at 37 °C with 5%
CO2. Stocks of PRRSV (strain PA8) and recombinant
vaccinia virus expressing T7 RNA polymerase (vTF7-3;
Fuerst et al., 1986) were prepared in Marc-145 or HeLa cells,
respectively, as described previously (Wootton et al., 2001).
The N protein-specific monoclonal antibody (MAb)
SDOW17, the E protein-specific anti-peptide rabbit antiserum
and non-structural proteins 2 and 3-specific polyclonal rabbit
antiserum are described elsewhere (Lee et al., 2005; Lee and
Yoo, 2005; Nelson et al., 1993; Wootton et al., 2001). E. coli
strains XL1-Blue (Stratagene) and DH5α were used as hostsfor site-directed mutagenesis and general cloning, respec-
tively. cDNA cloning of the PRRSV N or E gene to produce
pCITE-N; pGEX-N or pCITE-E; pGEX-E, respectively, is
described elsewhere (Wootton and Yoo, 2003; Lee and Yoo,
2005).
Generation of the E gene-knockout full-length PRRSV cDNA
clone
To modify the translational initiation codon of PRRSV
ORF2b (E), PCR-based site-directed mutagenesis was first
conducted to mutate the ATG start codon of the E gene to GTG
at genomic nucleotide positions 12,062 to 12,064 using the
shuttle vector pTB-shuttle-PRRSV-3997 (Lee et al., 2005) with
the following primer pairs; for A12062G mutation, E-KO-Fwd
(5′-GAATTGAAATGAAgTGGGGTCTATAC-3′: nucleotide
positions 12,049 to 12,074) and E-KO-Rev (5′-GTATA-
GACCCCAcTTCATTTCAATTC-3′: nucleotide positions
12,049 to 12,074), where lowercase letters indicate mutated
nucleotides. The A12062G mutation was translationally silent
with respect to ORF2a encoding the GP2 protein. PCR-based
mutagenesis and screening of mutants were performed as
described previously (Wootton et al., 2001). The shuttle plasmid
carrying the A12062G mutation was digested with Eco47III
and BsrGI, and a 908-bp fragment was purified. The wild-type
full-length genomic cDNA clone was digested with Eco47III
and BsrGI, and the 908-bp Eco47III–BsrGI fragment was
replaced with the corresponding fragment obtained from the
shuttle plasmid. The ligated full-length plasmid DNA was
screened by XmaI digestion, and based on the XmaI digestion
pattern, positive clones were selected. DNA manipulation and
cloning were performed according to standard procedures
(Sambrook and Russell, 2001). The selected clones were
sequenced to confirm the presence of the A12062G mutation in
the full-length genomic cDNA clone. The resulting plasmid was
designated pCMV-S-P129-ΔE.
Immunofluorescence
Marc-145 cells or BHK-21 cells were seeded on microscope
coverslips placed in 35-mm-diameter dishes and grown over-
night to 70% confluence. The cells were transfected with 2 μg
of plasmid DNA using Lipofectin (Invitrogen) according to the
manufacturer's instructions. At 48 h post-transfection, cell
monolayers were washed twice in PBS and fixed immediately
with cold methanol for 10 min at −20 °C. For time course
experiments, Marc-145 cells inoculated with purified passage-1
viruses prepared in the transfected BHK-21 cells were fixed at
various time points after infection. Cells were blocked using 1%
bovine serum albumin (BSA) in PBS for 30 min at room
temperature (RT) and then incubated with N-specific MAb
SDOW17 for 2 h. After washing five times in PBS, the cells
were incubated for 1 h at room temperature with goat anti-
mouse secondary antibody conjugated with Alexa green dye
(Molecular Probes). For dual immunofluorescence, cells were
co-stained with nsp2/3-specific rabbit antiserum and N-specific
MAb SDOW17, followed by incubation with goat anti-rabbit
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goat anti-mouse antibody conjugated with Alexa green. The
coverslips were washed five times in PBS and mounted on
microscope glass slides in mounting buffer (60% glycerol and
0.1% sodium azide in PBS). Cell staining was visualized using a
fluorescent microscope (model AX70; Olympus).
Preparation of radiolabeled viral particles and
immunoprecipitation
BHK cells were seeded in 100 mm-diameter dishes and
grown to 70% confluence. Cells were transfected for 20 h with
10 μg of the full-length cDNA plasmid using Lipofectin. The
transfected cells were continued for incubation at 37 °C in
DMEM supplemented with 8% FBS for 10 h. At 30 h post-
transfection, the cells were starved for 30 min in methionine-
deficient MEM (Invitrogen) and metabolically labeled for 24 h
with 100 μCi/ml of EasyTag EXPRESS protein labeling mix
([35S]methionine and [35S]cysteine, specific activity, 407 MBq/
ml) (Perkin-Elmer). After a 1-day labeling period, the cells were
washed twice with cold PBS and lysed with RIPA buffer (1%
Triton X-100, 1% sodium deoxycholate, 150 mM NaCl, 50 mM
Tris–HCl [pH 7.4], 10 mM EDTA, 0.1% SDS) containing
1 mM phenylmethylsulfonyl fluoride (PMSF). To prepare
radiolabeled viral particle samples, the culture supernatant was
harvested, and the cell debris was removed by a low-speed
centrifugation at 3500 rpm (model 5415; Eppendorf) for 10 min
at RT. The virus particles were purified through a 20% sucrose
cushion (wt/vol) prepared in TE buffer (10 mM Tris HCl [pH 8],
1 mM EDTA) at 40,000 rpm for 2 h at 4 °C in an SW41 rotor
(model XL-90; Beckman). The resulting pellets were resus-
pended in 50 μl of RIPA buffer containing 1 mM PMSF.
For immunoprecipitation, the dissolved pellets or cell lysates
equivalent to 1 in 15 of a 100-mm-diameter dish were adjusted
with RIPA buffer to a final volume of 100 μl and incubated for
2 h at RT with a mixture of E-specific rabbit antiserum, N-
specific MAb SDOW17, and M-specific rabbit antiserum. The
immune complexes were adsorbed to 7 mg of protein-A
Sepharose CL-4B beads (Amersham Biosciences) for 16 h at
4 °C. The beads were collected by centrifugation at 6000 rpm
for 5 min, washed twice with RIPA buffer and once with wash
buffer (50 mM Tris–HCl [pH 7.4], 150 mM NaCl). The beads
were resuspended in 20 μl of SDS–PAGE sample buffer
(10 mM Tris–HCl [pH 6.8], 25% glycerol, 10% SDS, 0.12%
[wt/vol] bromophenol blue) with 10% β-mercaptoethanol
(βME), boiled for 5 min and analyzed by 15% SDS–
polyacrylamide gel electrophoresis (PAGE). Gels were dried
on filter paper and radiographic images were obtained using a
phosphorimager (model PhosphorImager SI; Molecular
Dynamics).
Virus preparation from full-length cDNA clones
BHK-21 cells were transfected with the full-length cDNA
plasmid as described above. After washing of cells with DMEM
at 20 h post-transfection, the transfected cells were further
maintained in DMEM supplemented with 8% FBS for 2 daysand the culture supernatants were harvested at 2 days post-
transfection. The viral particles were purified as described
above and the pellets were suspended in DMEM. The resulting
virus suspension was designated ‘passage-1’. The passage-1
virus was used to inoculate fresh Marc-145 cells and the 5-day
harvest was designated ‘passage-2’. The ‘passage-3’ virus was
prepared in the same way as for passage-2. Each passage virus
was aliquoted and stored at −80 °C until use.
Electron microscopy of viral particles
Culture supernatants of BHK-21 cells transfected with the
full-length cDNA plasmid were harvested at 2 days post-
transfection as described above. The culture fluids were
centrifuged at 3500 rpm (model 5415; Eppendorf) for 10 min
to remove cellular debris. The cleared supernatants were
purified as described above, and the pellets were suspended in
50 μl of PBS and subsequently stored at 4 °C until use. Twenty
microliters of the virion suspension was mounted on a Formar-
coated copper grid. The grids were placed at RT for 5 min, and
excess liquid was removed by wicking with filter paper. For
negative staining, 20 μl of 2% sodium phosphotungstate (pH
6.8) was dropped onto the grids and incubated at RT for 30 s.
The samples were viewed with a transmission electron
microscope (model H-7600 120 keV PC-TEM; Hitachi)
operating at 75 keV.
RT-PCR and sequencing
Viral RNA was extracted from either supernatants or
lysates of infected cells using the QiaAmp viral RNA mini-kit
(Qiagen). To remove any contaminated DNA in the RNA
preparations, samples were treated with 1 U of RQ DNase I
(Promega) at 37 °C for 30 min in 50 mM Tris–HCl [pH 7.5]
and 1 mM MgCl2. For detection of viral RNA in the virions,
samples were prepared as previously described (Wieringa et
al., 2004) with some modifications. The viral particles in the
culture supernatant from BHK-21 cells transfected with the
full-length cDNA plasmid were pelleted by as described
above. The pellet was resuspended in TNM buffer (20 mM
Tris–HCl [pH 7.5], 50 mM NaCl, 5 mM MgCl2). Seventy
microliters of each sample suspension were added with 2 μl
of RQ DNase I (1 U/μl; Promega) and 3.6 μl of RNase A
(10 mg/ml; Sigma), and the mixture was incubated for 1 h at
37 °C in the presence or absence of detergents (1 μl of Triton
X-100, and 3.5 μl of 10% SDS). After incubation for 1 h at
37 °C, the nucleases were inactivated by the addition of 5 μl
of proteinase K (20 mg/ml; Qiagen) and incubation for
30 min at 50 °C. RNA was isolated from each sample by
using a QIAamp viral RNA mini-kit and subsequently, treated
one more time with 1 unit of RQ DNase I. After DNase I
treatment, RNA was re-extracted with an equal volume of
phenol:chloroform:isoamyl alcohol (25:24:1) mixture and
precipitated at −80 °C for 1 h by adding 0.1 volume of
2.5 M sodium acetate (pH 5.2) and 2 volumes of ethanol. The
pellets were washed once with 70% ethanol and dissolved in
UltraPure DNase/RNase-Free Distilled Water (Invitrogen).
Table 1
List of primers used for strand-specific RT-PCR
Primer name Nucleotide sequence Purpose Location (nt)
A-Fwd 5′-CCTAAACGGACCTATCGTCG-3′ Strand-specific RT 1149–1168
B-Fwd 5′-TGTCCGTTCGTGAAACCC-3′ Strand-specific PCR 1400–1417
B-Rev 5′-TGCAGGGAGTCTGAGGATTTGG-3′ Strand-specific PCR 1623–1644
C-Rev 5′-GCATGTCCCATCATTCTCCACAGG-3′ Strand-specific RT 6270–6293
D-Fwd 5′-GTGTTTACCATCGACGGG-3′ Strand-specific PCR 5689–5706
D-Rev 5′-AGAAGTTGGACGGTGGAGAGGC-3′ Strand-specific PCR 6233–6254
50 bp-Fwd 5′-GGAGCTGTGACCATTGGCA-3′ Strand-sp. RT and PCR 46–64
ORF7-Rev 5′-AGAATGCCAGCCCATCA-3′ Strand-specific PCR 15258–15274
3′UTR-Rev 5′-TTAATTTCGGCCGCATGGTTCT-3′ Strand-specific RT 15392–15413
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synthesis by Moloney Murine Leukemia Virus (M-MLV)
reverse transcriptase (Invitrogen) using the reverse primer
ORF2b-Rev (5′-TCATAAGATCTTCTGTAATTGCTC-3′).
The E gene was amplified by Taq DNA polymerase
(Invitrogen) using mRNA2-Fwd (5′-CCGTCATTGAAC-
CAACTTTA-3′) and ORF2b-Rev. For strand-specific RT-
PCR, the specific primer pairs (Table 1) were used to amplify
DNA fragments representing positive-sense genomic RNA,
negative-sense genomic RNA, positive-sense subgenomic
mRNA7 or negative-sense subgenomic mRNA7. PCR was
conducted under the following conditions; initial denaturation
at 95 °C for 5 min, 35 cycles of denaturation at 95 °C for
30 s, annealing at 56 °C for 30 s and extension at 72 °C for
1 min, followed by a final extension at 72 °C for 10 min.
PCR products were analyzed by 0.8% or 1.5% agarose gel
electrophoresis depending on size of the fragment. Amplified
products were purified using the PCR purification kit
(Qiagen) and sequenced.
The effect of ion channel inhibitors on PRRSV infection
Stock solutions of ammonium chloride, chloroquine,
amantadine and verapamil (Sigma) were prepared in water at
concentrations of 50 mM, 2 mM, 10 mM and 1 mM,
respectively. Marc-145 cells grown in 6-well plates were pre-
incubated with different concentrations of the reagents for
30 min and subsequently infected with PRRSVat a multiplicity
of infection (MOI) of 1 for 1 h at 37 °C in the presence or
absence of the drugs. The virus inoculum was removed and the
cells washed three times with MEM. The inoculated cells were
then incubated in fresh medium in the presence or absence of
the reagents and monitored daily for the appearance of CPE.
Culture supernatants were harvested daily from cells for 3 days
and virus titer in the supernatant was determined by plaque
assay. At 1 day or 2 days post-infection, Marc-145 cells infected
with PRRSV in presence or absence of the drugs were fixed
with cold methanol and subjected to an immunofluorescence
assay as described above. The effect of ion channel blockers on
PRRSV replication was also determined by strand-specific RT-
PCR. Total cellular RNA was extracted from mock-infected or
PRRSV-infected cells in presence or absence of the drugs using
TRIzol (Invitrogen) and DNA fragments representing positive-
sense or negative-sense viral genomic RNA were RT-PCRamplified using ORF7-specific primers (Lee et al., 2006) or
negative-sense-specific primers (Table 1), respectively, as
described above.
Protein expression in E. coli and hygromycin B permeability
assay
An inducible E. coli expression system was used to express
the PRRSV E protein fused with glutathione S-transfererase
(GST). Plasmids were transformed into E. coli strain DH5α to
express GST fusion proteins. A single colony was grown in
Luria Bertani (LB) media containing 100 μg/ml ampicillin
overnight. One hundred ml of LB media containing 100 μg/ml
ampicillin was inoculated with 1/100 of overnight culture.
When the absorbance of cultures reached at an OD600 of 0.6,
1 mM isopropylthio-β-D-galactoside (IPTG) was added to the
media to induce protein synthesis. At indicated times after
induction, the densities of bacterial cultures were determined by
measuring the light scattering at 600 nm.
Permeability of the plasma membrane of bacterial cells
expressing the PRRSV E protein to hygromycin B was
determined as described previously (Liao et al., 2004). Briefly,
bacterial cultures were incubated in the presence or absence of
1 mM of hygromycin B for 15 min at 1 h after IPTG induction,
and aliquots of l ml were labeled with for 15 min with 4 μCi/ml
of [35S]methionine/cysteine. The labeled bacterial cells were
then harvested and lysed in equal volumes of SDS–PAGE
sample buffer. Proteins were resolved on a 12% SDS–PAGE gel
and visualized by Coomassie blue staining or autoradiography.
Chemical cross-linking
The PRRSV N or E protein was independently expressed in
HeLa cells using the T7-based vaccinia virus vTF7-3. HeLa
cells seeded on 60-mm-diameter dishes were grown to 90%
confluence and infected for 1 h at 37 °C with vTF7-3 at an MOI
of 10. Following infection, fresh medium was added and
incubation continued for an additional 1 h. The cells were
washed in OPTI-MEM and transfected with 1.5 μg of a plasmid
for 16 h using the reagent Lipofectin. The transfected cells were
then starved for 30 min in methionine-deficient MEM and
incubated for 5 h with 100 μCi/ml of [35S]methionine/cysteine.
To prepare radiolabeled PRRSV-infected cells, Marc-145 cells
seeded on a 100-mm-diameter dish were infected with PRRSV
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starved for 30 min in methionine-deficient MEM and
metabolically labeled for 10 h with 100 μCi/ml of [35S]
methionine/cysteine. For cross-linking studies, cells were
washed twice with cold PBS at the end of the labeling period,
and samples were incubated with 2 mM of the membrane-
permeable and thiol-cleavable cross-linker, 3,3′-dithiobis (suc-
cinimidylpropionate) (DSP, Pierce) prepared in 10% DMSO
(vol/vol in PBS) at room temperature for 30 min. The reaction
was quenched with 50 mM Tris–HCl [pH 7.5] and incubated for
an additional 15 min. The cells were lysed with lysis buffer
(50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1% NP-40)
containing 1 mM PMSF. The resultant cell lysates were then
used in immunoprecipitation with 1 μl of the N-specific MAb
SDOW 17 or 3 μl of the E-specific rabbit antiserum followed by
SDS–17% PAGE analysis and autoradiography as described
above.
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